Furthermore, the authors noted that the ratio of Treg/CD8+ T cells may be associated with the prognosis of HCC and may reflect the antitumour effect of PD1/PDL1 inhibitors [66]. The gene discussed is CD274; the disease is hepatocellular carcinoma.